Generali Investments Management Co LLC Takes Position in HCA Healthcare, Inc. $HCA

Generali Investments Management Co LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,407 shares of the company’s stock, valued at approximately $538,000.

Other hedge funds also recently made changes to their positions in the company. Brighton Jones LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at approximately $1,021,000. Dakota Wealth Management bought a new position in HCA Healthcare during the first quarter worth $221,000. Larson Financial Group LLC grew its holdings in HCA Healthcare by 29.4% during the 1st quarter. Larson Financial Group LLC now owns 938 shares of the company’s stock worth $324,000 after acquiring an additional 213 shares during the period. Graypoint LLC lifted its stake in shares of HCA Healthcare by 3.0% in the 1st quarter. Graypoint LLC now owns 1,831 shares of the company’s stock valued at $633,000 after purchasing an additional 54 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. grew its stake in HCA Healthcare by 75.8% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company’s stock worth $40,000 after purchasing an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

HCA has been the subject of several recent analyst reports. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research report on Monday, October 27th. JPMorgan Chase & Co. upped their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Truist Financial boosted their target price on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Raymond James Financial set a $525.00 price objective on HCA Healthcare in a research note on Monday, October 27th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $474.53.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.30% of the company’s stock.

HCA Healthcare Trading Down 0.2%

NYSE HCA opened at $472.40 on Friday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $480.00. The firm has a market capitalization of $107.80 billion, a P/E ratio of 18.26, a PEG ratio of 1.38 and a beta of 1.41. The business has a fifty day simple moving average of $433.56 and a 200 day simple moving average of $396.45.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.